Matriptase inhibitors and methods of use
First Claim
Patent Images
1. A compound of the formula wherein:
- R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C1-C8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted C1-C8 alkylthio, an optionally substituted C1-C8 alkylsulfinyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;
n is a value of 0 to about 6;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
or R1, R2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group;
or R1 and R3, or R2 and R3, together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R4 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
or R3, R4, or R2, R4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R5 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R4, R5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
or R5, R6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
‘
A’
is a member selected from the group consisting of an optionally substituted C1-C8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘
A’
can optionally have a heteroatom for attachment;
X is a heteroatom selected from the group consisting of S, O and N;
R7, if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonyloxy;
alternatively, A, R7, and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and
R8 and R9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C1-C8 alkoxycarbonyloxy, in an alternative embodiment, R7 and R9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring.
7 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides matriptase inhibitors and compositions thereof useful for treating cancer. Martripase is a trypsin-like serine protease active in the development of cancerous conditions, such as tumors and metastasis of cancer.
24 Citations
42 Claims
-
1. A compound of the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C1-C8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted C1-C8 alkylthio, an optionally substituted C1-C8 alkylsulfinyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;
n is a value of 0 to about 6;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
orR1, R2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group;
orR1 and R3, or R2 and R3, together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R4 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
orR3, R4, or R2, R4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R5 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R4, R5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
orR5, R6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
‘
A’
is a member selected from the group consisting of an optionally substituted C1-C8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘
A’
can optionally have a heteroatom for attachment;
X is a heteroatom selected from the group consisting of S, O and N;
R7, if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonyloxy;
alternatively, A, R7, and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and
R8 and R9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C1-C8 alkoxycarbonyloxy, in an alternative embodiment, R7 and R9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. A pharmaceutical composition, said pharmaceutical composition comprising:
-
wherein; R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C1-C8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted C1-C8 alkylthio, an optionally substituted C1-C8 alkylsulfinyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;
n is a value of 0 to about 6;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
orR1, R2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group;
orR1 and R3, or R2 and R3, together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R4 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
orR3, R4, or R2, R4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R5 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R4, R5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
orR5, R6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
‘
A’
is a member selected from the group consisting of an optionally substituted C1-C8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘
A’
can optionally have a heteroatom for attachment;
X is a heteroatom selected from the group consisting of S, O and N;
R7, if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonyloxy;
alternatively, A, R7, and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and
R8 and R9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C1-C8 alkoxycarbonyloxy, in an alternative embodiment, R7 and R9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring. - View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
is a member selected from the group consisting of: -
wherein R11 is a member selected from the group consisting of hydrogen, hydroxyl, and an optionally substituted C1-C8 alkyl; and
Q, Y and Z are each independently selected from the group consisting of an optionally substituted carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon and wherein the dotted line is an optional double bond.
-
17. The composition of claim 16, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted aryl, optionally substituted arylsulfonyl, and a carboxylic acid isostere;
n is a value of about 1 to 4;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted heteroaralkyl, and an optionally substituted carboxy; and
R5 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl.
-
-
18. The composition of claim 17, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted amino, and an optionally substituted carboxy an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted aralkylsulfonyl, optionally substituted arylsulfonyl, and an acid isostere;
n is a value of about 1 to 2;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted arylsulfonylcarbamoyl and hydroxy; and
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl.
-
-
19. The composition of claim 17, wherein R2 is selected from an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and hydroxy.
-
20. The composition of claim 17, wherein R2 is an optionally substituted C1-C8 alkoxycarbonyl.
-
21. The composition of claim 16, wherein said compound has the formula
wherein: R1 is a member selected from the group consisting of an C1-C6 alkyl, carboxyl group, C1-C6 alkyl-OC(O)NH—
, C1-C6 alkylOC(O)—
, C1-C6 alkylC(O)—
, C1-C6 alkylSO2—
, C1-C6 alkylOC(O)NR12 wherein R12 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl and NR13R14C(O)—
, wherein R13R14 are each independently selected from the group of hydrogen, and an optionally substituted C1-C8 alkyl.
-
22. The composition of claim 21, wherein said compound has the formula
wherein: R2 is selected from an optionally substituted alkylcarbamoyl group, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.
-
23. The composition of claim 21, wherein said compound has the formula
wherein: R2 is selected from an optionally substituted C1-C6 alkylcarbamoyl group, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.
-
24. The composition of claim 16, wherein said compound has the formula
wherein: R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group.
-
25. The composition of claim 16, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C1-C8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted C1-C8 alkylthio, an optionally substituted C1-C8 alkylsulfinyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group;
orR2 and R3, together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring.
-
-
26. The composition of claim 16, wherein said compound has the formula
wherein: R2 is selected from an optionally substituted C1-C6 alkylcarbamoyl group, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.
-
27. The composition of claim 15, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;
n is a value of about 1 to 2;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, and an optionally substituted carboxy; and
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl; and
Q, Y and Z are each independently selected from the group consisting of a carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon.
-
-
28. The composition of claim 27, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;
n is a value of about 1 to 2; and
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, and an optionally substituted carboxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy.
-
-
-
29. A method for treating a condition in a mammal by decreasing or inhibiting the serine protease activity of matriptase or MTSP1, wherein the condition is selected from the group consisting of leukemia, lymphomas, breast cancer, gastrointestinal cancer, esophageal cancer, stomach cancer, colon cancer, bowel cancer, colorectal cancer, prostate cancer, bladder cancer, testicular cancer, ovarian cancer, uterine cancer, cervical cancer, brain cancer, lung cancer, bronchial cancer, pancreatic cancer, thyroid cancer, bone cancer and skin cancer, said method comprising:
- administering an effective amount of a compound of the formula;
wherein; R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C1-C8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted C1-C8 alkylthio, an optionally substituted C1-C8 alkylsulfinyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;
n is a value of 0 to about 6;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroararyl, an optionally substituted cycloalkyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
orR1, R2 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group;
orR1 and R3, or R2 and R3, together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R4 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
orR3, R4, or R2, R4 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
R5 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl, an optionally substituted aralkyl, or, alternatively, R4, R5 and the atoms to which they are attached, join to form a 5- or 6-membered heterocyclic or heteroaryl ring;
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl;
orR5, R6 and the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring;
‘
A’
is a member selected from the group consisting of an optionally substituted C1-C8 alkylene, a five- or a six-membered optionally substituted cycloalkyl group, a 5 to 10-membered optionally substituted aryl group and a 5 to 10-membered optionally substituted heteroaryl group, wherein said 5 to 10-membered optionally substituted heteroaryl group has from 1 to 3 heteroatoms selected from the group consisting of optionally substituted N, O, and S, wherein ‘
A’
can optionally have a heteroatom for attachment;
X is a heteroatom selected from the group consisting of S, O and N;
R7, if present, is a member selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkanoyloxy, an optionally substituted alkylcarbamoyl, an optionally substituted alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonyloxy;
alternatively, A, R7, and the atoms to which they are attached, join to form a 5- to 10-membered optionally substituted heteroaryl group, wherein said 5- to 10-membered optionally substituted heteroaryl group has at least 1 optionally substituted nitrogen and the dotted line is either a bond or is absent; and
R8 and R9 are members independently selected from the group consisting of hydrogen, hydroxy, an optionally substituted C1-C8 alkyl, an optionally substituted alkoxy, an optionally substituted aryl, an optionally substituted C1-C8 alkanoyl, an optionally substituted alkanoyloxy, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted alkoxycarbonyl, and an optionally substituted C1-C8 alkoxycarbonyloxy, in an alternative embodiment, R7 and R9 and the atoms to which they are attached, join to form a 5- to 7-membered heterocyclic or heteroaryl ring, to decrease or inhibit the serine protease activity of matriptase or MTSP1. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)
is a member selected from the group consisting of: -
wherein R11 is a member selected from the group consisting of hydrogen, hydroxyl, and an optionally substituted C1-C8 alkyl; and
Q, Y and Z are each independently selected from the group consisting of an optionally substituted carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon and wherein the dotted line is an optional double bond.
-
31. The method of claim 30, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted amino, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted aryl, optionally substituted arylsulfonyl, and a carboxylic acid isostere;
n is a value of about 1 to 4;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted heteroaralkyl, and an optionally substituted carboxy; and
R5 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl.
-
-
32. The method of claim 31, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted amino, and an optionally substituted carboxy an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted aralkylsulfonyl, optionally substituted arylsulfonyl, and an acid isostere;
n is a value of about 1 to 2;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted heteroarylalkylsulfonamide, an optionally substituted arylsulfonylcarbamoyl and hydroxy; and
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl.
-
-
33. The method of claim 31, wherein R2 is selected from an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted ureido, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and hydroxy.
-
34. The method of claim 31, wherein R2 is an optionally substituted C1-C8 alkoxycarbonyl.
-
35. The method of claim 30, wherein said compound has the formula
wherein: R1 is a member selected from the group consisting of an C1-C6 alkyl, carboxyl group, C1-C6 alkyl-OC(O)NH—
, C1-C6 alkylOC(O)—
, C1-C6 alkylC(O)—
, C1-C6 alkylSO2—
, C1-C6 alkylOC(O)NR12 wherein R12 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl and NR13R14C(O)—
, wherein R13R14 are each independently selected from the group of hydrogen, and an optionally substituted C1-C8 alkyl.
-
36. The method of claim 35, wherein said compound has the formula
wherein: R2 is selected from an optionally substituted alkylcarbamoyl group, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.
-
37. The method of claim 35, wherein said compound has the formula
wherein: R2 is selected from an optionally substituted C1-C6 alkylcarbamoyl group, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfamoyl, an optionally substituted alkylsulfamoyl, an optionally substituted arylsulfamoyl, an optionally substituted heteroarylsulfamoyl, and an optionally substituted ureido.
-
38. The method of claim 30, wherein said compound has the formula
wherein: R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group.
-
39. The method of claim 30, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkyl, an optionally substituted C1-C8 alkoxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carboxy, an optionally substituted carboxyalkyl, an optionally substituted carboxyalkenyl, an optionally substituted C1-C8 alkanoyl, an optionally substituted carbamoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylalkyl, an optionally substituted C1-C8 alkylthio, an optionally substituted C1-C8 alkylsulfinyl, an optionally substituted C1-C8 alkylsulfonyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aryl, an optionally substituted arylsulfinyl, an optionally substituted arylsulfonyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonyl, an optionally substituted amino, and an acid isostere;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted carboxyalkyl, an optionally substituted heteroaryl, an optionally substituted aralkyl, an optionally substituted heteroaralkyl, an optionally substituted heteroaralkenyl, an optionally substituted heteroararyl, and an optionally substituted cycloalkyl group;
orR2 and R3, together with the atoms to which they are attached, join to form an optionally substituted 5- or 6-membered heterocyclic or carbocylic ring.
-
-
40. The method of claim 30, wherein said compound has the formula
wherein: R2 is selected from an optionally substituted C1-C6 alkylcarbamoyl group, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl, an optionally substituted carbamoyl, an optionally substituted heteroarylalkylsulfonamide, and an optionally substituted ureido.
-
41. The method of claim 29, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;
n is a value of about 1 to 2;
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, an optionally substituted carboxy, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy;
R3 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkoxycarbonyl, and an optionally substituted carboxy; and
R6 is a member selected from the group consisting of hydrogen, an optionally substituted C1-C8 alkyl, and an optionally substituted aryl; and
Q, Y and Z are each independently selected from the group consisting of a carbon, an optionally substituted nitrogen, an oxygen and a sulfur, provided however at least one of Q, Y and Z is carbon.
-
-
42. The method of claim 41, wherein said compound has the formula
wherein: -
R1 is a member selected from the group consisting of an optionally substituted C1-C8 alkoxy, an optionally substituted carboxy, an optionally substituted C1-C8 alkanoyl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted carbamoyl, an optionally substituted amino, and an optionally substituted carboxy;
n is a value of about 1 to 2; and
R2 is a member selected from the group consisting of an optionally substituted aryl, an optionally substituted C1-C8 alkylcarbamoyl, an optionally substituted C1-C8 alkoxycarbonyl, an optionally substituted amino, and an optionally substituted carboxy, an optionally substituted C1-C8 alkoxycarbonylamino, an optionally substituted ureido, an optionally substituted sulfamoyl, an optionally substituted C1-C8 alkylsulfonylcarbamoyl, an optionally substituted arylsulfonylcarbamoyl, an optionally substituted aralkylsulfonylcarbamoyl and hydroxy.
-
- administering an effective amount of a compound of the formula;
Specification